# Corventis

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corventis

- Industry: Medical Devices & Equipment
- Headquarters: San Jose, US
- Website: www.corventis.com
- Total disclosed funding: $20M
- Latest round: Series B (Mar 5, 2008)
- Investors on record: 3

## About

Corventis, Inc. is a medical technology company focused on developing advanced cardiac monitoring solutions that enhance patient care through innovative and reliable diagnostic systems.Corventis, Inc. specializes in cardiac monitoring technology, offering products that assist in the detection of arrhythmias. Founded in San Jose, US, the company was acquired by Medtronic in May 2014. The company has completed a total of three funding deals, with the latest round being USD 10.00 mn raised from Kleiner Perkins, which matches the total amount raised to date.Corventis, Inc. develops and sells advanced cardiac monitoring devices that utilize subcutaneous electrocardiograms (ECGs). Their primary offerings include systems designed to track cardiac activity for patients at risk of arrhythmias, catering to both adult and pediatric populations. Their products are marketed across North America, Europe, and select Asia-Pacific regions, targeting hospitals and specialty clinics focused on cardiology.Corventis, Inc. generates revenue through direct sales of its cardiac monitoring devices to healthcare institutions. This B2B model allows healthcare providers to prescribe these advanced technologies to patients, enhancing cardiac evaluation processes. The company may also provide additional support services, contributing to ongoing revenue streams.With the recent acquisition by Medtronic, Corventis, Inc. is expected to leverage its resources to enhance product offerings and expand into new markets. Future initiatives include the development of new cardiac monitoring technologies aimed for release in the upcoming years. The funding secured in May 2014 will support these growth strategies, focusing on increasing market presence and developing innovative medical devices that address growing needs in cardiac care.

## Funding rounds

- Series B, Mar 5, 2008, $20M — Kleiner Perkins, Mohr Davidow Ventures, DAG Ventures

## Investors

- Kleiner Perkins (https://capitalatlas.ai/funds/kleiner-perkins) — Series B
- Mohr Davidow Ventures (https://capitalatlas.ai/funds/mohr-davidow-ventures) — Series B
- DAG Ventures (https://capitalatlas.ai/funds/dag-ventures) — Series B